[HTML][HTML] Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective

J Dai, P Yang, A Cox, G Jiang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary
diseases that commonly coexist and present a number of clinical challenges. COPD confers …

Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: A review

H Doi, K Nakamatsu, Y Nishimura - International Journal of Clinical …, 2019 - Springer
Stereotactic body radiation therapy (SBRT) can yield excellent local tumor control, as well as
survival benefit comparable to that of surgery for early-stage lung cancer. However, in terms …

Impact of coexistent preserved ratio impaired spirometry on the survival of patients with lung cancer: analysis of data from the Korean Association for Lung Cancer …

IR Heo, HC Kim, SJ Lee, JW Yoo, S Ju… - Thoracic …, 2021 - Wiley Online Library
Background Preserved ratio impaired spirometry (PRISm) is a common spirometric pattern
that is associated with respiratory symptoms and higher mortality rates. However, the …

[HTML][HTML] Pulmonary function is implicated in the prognosis of metastatic non-small cell lung cancer but not in extended disease small cell lung cancer

SY Lee, YJ Choi, JH Seo, SY Lee, JS Kim… - Journal of Thoracic …, 2019 - ncbi.nlm.nih.gov
Background The impacts of pulmonary function in patients with metastatic non-small cell
lung cancer (NSCLC) and extended disease stage small cell lung cancer (SCLC-ED) …

Associations between time to treatment start and survival in patients with lung cancer

T Stokstad, S Sørhaug, T Amundsen, BH Grønberg - in vivo, 2021 - iv.iiarjournals.org
Background: Time-to-treatment is defined as a quality indicator for cancer care but is not well
documented. We investigated whether meeting Norwegian timeframes of 35/42 days from …

Survival of localized NSCLC patients without active treatment or treated with SBRT

SS Jeppesen, NCG Hansen, T Schytte… - Acta Oncologica, 2018 - Taylor & Francis
Background: Little information on the natural history of patients with localized NSCLC is
available since many of the studies covering the subject lack information on pathological …

Parenchymal and Functional lung changes after stereotactic Body radiotherapy for early-stage non-small cell lung cancer—experiences from a single institution

J Hörner-Rieber, J Dern, D Bernhardt, L König… - Frontiers in …, 2017 - frontiersin.org
Introduction This study aimed to evaluate parenchymal and functional lung changes
following stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer …

Salivary metabolic profile of patients with lung cancer, chronic obstructive pulmonary disease of varying severity and their comorbidity: A preliminary study

LV Bel'skaya, EA Sarf, DV Solomatin, VK Kosenok - Diagnostics, 2020 - mdpi.com
The aim of the work was to study the features of the salivary biochemical composition in the
combined pathology of lung cancer and chronic obstructive pulmonary disease (COPD) of …

Rethink radiotherapy–BIGART 2017

C Grau, M Høyer, PR Poulsen, LP Muren… - Acta …, 2017 - Taylor & Francis
The present issue of Acta Oncologica contains studies presented at the 15th Acta
Oncologica Symposium, held in Aarhus, Denmark on June 13-16, 2017. The symposium …

Clinical and genetic associations between lung cancer and chronic obstructive pulmonary disease

J Dai - 2018 - etheses.whiterose.ac.uk
Lung cancer and chronic obstructive pulmonary disease (COPD) are both leading causes of
death in the world, and these two disease are closely linked in the clinical setting and at the …